Texas Medical Center Research: What the World's Largest Med Campus Is Working On

The Texas Medical Center sprawls across 1,345 acres just south of the Medical Center neighborhood. Sixty-one member institutions, 120,000 employees, more than 10 million patient visits a year, and an annual research budget north of $2 billion. It is the single largest concentration of medical research and clinical care on the planet, and most Houstonians drive past it without realizing what's happening inside.

This is a high-level survey of where TMC's research arm is putting its weight — the labs and programs likely to shape clinical care over the next decade.

Cancer: MD Anderson and the next wave of immunotherapy

MD Anderson Cancer Center is the largest tenant by research dollars. The Moon Shots Program — launched in 2012 with the goal of dramatically reducing mortality across 15 cancer types — is now in its second decade and has driven major work on CAR-T cell therapy, immune-checkpoint combinations, and the early-detection biomarkers behind the rising number of curative-intent treatments for previously terminal diagnoses. The MD Anderson Pancreatic Cancer Moon Shot in particular has changed survival trajectories for one of oncology's hardest indications.

Heart and transplant: Texas Heart Institute, Methodist DeBakey, and Baylor

Houston's cardiovascular pedigree runs through Denton Cooley and Michael DeBakey. Their successors at the Texas Heart Institute (St. Luke's) and the DeBakey Heart and Vascular Center at Houston Methodist remain global leaders in mechanical circulatory support, total artificial hearts, and minimally invasive valve replacement. Baylor College of Medicine's transplant program is a national leader in xenotransplantation — gene-edited pig organs into human recipients — and ran one of the first FDA-approved xenokidney trials starting in 2024.

TMC3: the new collaborative research campus

The biggest structural change in years is TMC3 — a $1.85 billion, 37-acre campus built to mash up TMC's clinical institutions with industry partners and translational labs. Anchor tenants include Baylor, UTHealth, MD Anderson, and Texas A&M Health, plus dedicated industry space for biotech and medical-device companies. The first phase opened in 2024. TMC's bet is that breakthroughs come from co-locating clinicians, researchers, and engineers in the same buildings — the same model that worked for Kendall Square in Cambridge and is being copied in San Diego and Raleigh.

Neuroscience, infectious disease, and the next decade

Three programs to watch: the Memorial Hermann–Texas Medical Center Stroke Center, one of the country's busiest endovascular thrombectomy practices, has been generating practice-changing data on stroke time windows. The Baylor National School of Tropical Medicine continues to lead vaccine development for neglected tropical diseases — and yes, the same lab that helped develop a low-cost protein-subunit COVID vaccine remains active. And the McGovern Medical School's neurorestoration program is doing clinical work on deep-brain stimulation for treatment-resistant depression that has been one of the most surprising stories in psychiatry.

Visitors who want a real look at the campus can take the Texas Medical Center tour (free, weekday mornings) or simply ride the METRORail Red Line — the line was built largely to serve TMC, with seven stations on the campus. For visitors building a science-themed Houston trip, combining TMC with NASA Johnson Space Center gives you both of Houston's world-class research institutions in two days.